Retrospective analysis of real-world clinico-genomic data for clinical impact of genomic profiling of CTDNA in NSCLC Published September 2019 Citation Madison, R, Schrock, AB, Gregg, JP, Carson, KR, Castellanos, EH, Singal, G, Miller, VA, Ali, SM, Alexander, BM, Chung, JH. . World Conference on Lung Cancer. . https://wclc2019.iaslc.org/wp-content/uploads/2019/08/WCLC2019-Abstract-Book_web-friendly.pdf#page=389 Authors:Madison, R, Schrock, AB, Gregg, JP, Carson, KR, Castellanos, EH, Singal, G, Miller, VA, Ali, SM, Alexander, BM, Chung, JH Sources:World Conference on Lung Cancer Share Posted inPublicationsTreatment patternsNon-small cell lung cancer More publicationsWorld Conference on Lung CancerAugust 2025Evolving treatment patterns in early-stage non-small cell lung cancer in the USGray J E, Thoele K, Gilligan A M, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world biomarker testing and treatment initiation in patients with resected early-stage NSCLC (eNSCLC) in the US and UKRinaldi C, Halloran S, Pittel H, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world treatment patterns and clinical outcomes in patients with metastatic neuroendocrine neoplasms of the lung (NEN-L)Zu K, Vaidya R, Cho-Phan C, Hu H.Publication summaryPublicationsTreatment patternsNon-small cell lung cancer